ISSN: 2651-4532 / E-ISSN: 2452-3364
Journal of Oncological Science (J Oncol Sci) is the official journal of Turkish Society of Medical Oncology. J Oncol Sci is an international multidisciplinary oncology journal, which publishes high quality original research, reviews, short communications (as letters), case reports and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology - including medical oncology, pediatric oncology, radiation oncology, surgical oncology, therapeutic radiology and cancer epidemiology and prevention.
Papers will be submitted in submission web site. Editorial office will rapidly review papers and those of insufficient quality will be returned to the author 3 weeks, while those with sufficient priority will be passed to external review.
J Oncol Sci is an online-only, open access, peer-reviewed journal. With a large international editorial board of experts, J Oncol Sci aims to advance clinically-relevant knowledge of cancer, and improve prevention, diagnosis and treatment of malignant disease. It provides an integrated view of oncology across all disciplines. The emphasis will be on publishing high quality papers rapidly and freely available to researchers worldwide.
J Oncol Sci is published every 4 months (total of 3 issues per year).
Open Access Journal
This journal is a peer reviewed, subsidized open access journal where Turkish Society of Medical Oncology pays the OA fee. Authors do not have to pay any open access publication fee. Peer review under the responsibility of Turkish Society of Medical Oncology.
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute.
Permitted third party reuse is defined by the following user license:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND):
Allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
Note: If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication.
For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to Turkish Society of Medical Oncology, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
This journal is published three times a year.